Loading market dashboard
Astrana Health, Inc.
ASTHHealthcareNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
ALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it has been named to the Fortune 1000® for 2026, marking its debut on the annual ranking of the largest U.S. companies by revenue.
Astrana Health NASDAQ: ASTH CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue.
Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
ALHAMBRA, Calif., May 12, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointment of George Christides, M.D.
Expands access to Astrana's Medicare ACO platform, powered by a unified AI-powered platform designed for independent physicians ALHAMBRA, Calif., May 11, 2026 /PRNewswire/ -- The Physician Association of California ("PAC") and Astrana Health, Inc. ("Astrana") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced a collaboration to help independent primary care physicians remain independent – and succeed – in an increasingly complex healthcare system while improving patient care.
Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.14 per share a year ago.
Company to Host Conference Call on Thursday, May 7, 2026, at 2:30 p.m. PT/5:30 p.m.
Investors need to pay close attention to ASTH stock based on the movements in the options market lately.
ALHAMBRA, Calif., April 21, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2026, after the close of the stock market on Thursday, May 7, 2026.
On April 16, 2026, Astrana Health Inc (ASTH) shares rose 4.7%, bringing the current price to $30.60. The stock has shown a strong performance over the past mont
Valuation Assessment of Astrana Health Inc (ASTH) On April 13, 2026, Astrana Health Inc (ASTH) shares rose 4.5% today, bringing the current price to $28.88. The
ALHAMBRA, Calif., April 10, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The 25th Annual Needham Virtual Healthcare Conference on April 13-16, 2026 The Bank of America Global Healthcare Conference 2026, being held in Las Vegas on May 12-14, 2026, including a fireside chat on May 12th at 3:40pm PT.
Astrana Health, Inc. offers a mispriced growth opportunity, combining 20–30% top and bottom line growth with strong free cash flow and operational leverage. ASTH's risk-bearing, tech-enabled model drives industry-leading G&A efficiency (6.8%), diversified revenue streams, and resilience against reimbursement or membership volatility. Despite 56% revenue growth and robust EBITDA expansion, ASTH trades at deep valuation discounts (EV/Revenue 0.43x, EV/EBITDA 6.43x), reflecting over-discounted risk.
JPMorgan Chase and Co. trimmed its holdings in Astrana Health, Inc. (NASDAQ: ASTH) by 30.3% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 64,298 shares of the company's stock after selling 27,903 shares during the quarter. JPMorgan Chase and Co. owned 0.11%
Astrana Health, Inc. (ASTH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Recognition places Foothill Regional among the top 5% in the nation for patient safety TUSTIN, Calif., March 10, 2026 /PRNewswire/ -- Foothill Regional Medical Center, part of Astrana Health, Inc. (NASDAQ: ASTH), has been recognized as a 2026 Patient Safety Excellence Award™ recipient by Healthgrades, the nation's leading resource Americans use when searching for a hospital or doctor.
Intech Investment Management LLC lowered its position in Astrana Health, Inc. (NASDAQ: ASTH) by 42.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,971 shares of the company's stock after selling 26,250 shares during the
